Editorial: NK Cells in Human Diseases: Friends or Foes?

por Vieillard, Vincent, Foley, Bree, López-Vergès, Sandra L.
Publicado 2017

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies

por Barnes, Samantha A., Trew, Isabella, de Jong, Emma, Foley, Bree
Publicado 2021

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

por Barnes, Samantha, Schilizzi, Ophelia, Audsley, Katherine M., Newnes, Hannah V., Foley, Bree
Publicado 2020

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells

por Barnes, Samantha A., Audsley, Katherine M., Newnes, Hannah V., Fernandez, Sonia, de Jong, Emma, Waithman, Jason, Foley, Bree
Publicado 2022

Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens

por Wylie, Ben, Chee, Jonathan, Forbes, Catherine A, Booth, Mitchell, Stone, Shane R, Buzzai, Anthony, Abad, Ana, Foley, Bree, Cruickshank, Mark N, Waithman, Jason
Publicado 2019

Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells

por Barrett, Lucy W, Fear, Vanessa S, Foley, Bree, Audsley, Katherine, Barnes, Samantha, Newnes, Hannah, McDonnell, Alison, Wood, Fiona M, Fear, Mark W, Waithman, Jason
Publicado 2022

CD8(+)XCR1(neg) Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors

por Wylie, Ben, Read, James, Buzzai, Anthony C., Wagner, Teagan, Troy, Niamh, Syn, Genevieve, Stone, Shane R., Foley, Bree, Bosco, Anthony, Cruickshank, Mark N., Waithman, Jason
Publicado 2019

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes

por Buzzai, Anthony C., Wagner, Teagan, Audsley, Katherine M., Newnes, Hannah V., Barrett, Lucy W., Barnes, Samantha, Wylie, Ben C., Stone, Shane, McDonnell, Alison, Fear, Vanessa S., Foley, Bree, Waithman, Jason
Publicado 2020

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia

por Foley, Bree, Ta, Clara, Barnes, Samantha, de Jong, Emma, Nguyen, Michelle, Cheung, Laurence C, Buzzai, Anthony, Wagner, Teagan, Wylie, Ben, Fernandez, Sonia, Cruickshank, Mark, Endersby, Raelene, Kees, Ursula, Waithman, Jason
Publicado 2020

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies

por Audsley, Katherine M., Wagner, Teagan, Ta, Clara, Newnes, Hannah V., Buzzai, Anthony C., Barnes, Samantha A., Wylie, Ben, Armitage, Jesse, Kaisho, Tsuneyasu, Bosco, Anthony, McDonnell, Alison, Cruickshank, Mark, Fear, Vanessa S., Foley, Bree, Waithman, Jason
Publicado 2021

New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment

por Cheung, Laurence C., Tickner, Jennifer, Hughes, Anastasia M., Skut, Patrycja, Howlett, Meegan, Foley, Bree, Oommen, Joyce, Wells, Julia E., He, Bo, Singh, Sajla, Chua, Grace-Alyssa, Ford, Jette, Mullighan, Charles G., Kotecha, Rishi S., Kees, Ursula R.
Publicado 2018